INS and diabetes mellitus: In this study, supplementation of patients with diabetes with SK (daily dose of 500 mg) improved weight, glycemic indices (FBS, HbA1C, and Fasting Insulin), and lipids (total cholesterol, LDL-c, and HDL-c) outcomes (except for triglycerides level) in the intervention group compared to the placebo group.